Ring Christine — SEC insider filings
SEC reporting owner CIK 1817199. 71 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers the 50 most recent of 71 filings on record, filed 2023-02-01 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 57 legs across 46 filings — 297,362 shares, $5,907,616 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 154.
- Largest priced transaction: sale of 37,600 shares @ $17.07 ($641,697) in Nurix Therapeutics, Inc., filed 2025-11-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | Chief Legal Officer | 50 | — | 57 legs · 297,362 sh · $5,907,616 | 154 |
Insider filings — Ring Christine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,786 @ $8.72 · Sale (S): 9,527 @ $25.74 · Sale (S): 1,075 @ $26.76 · Sale (S): 6,113 @ $25.83 · Option exercise (M): 5,786 (derivative) @ $0 | EDGAR |
| 2026-11-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Option exercise (M): 3,573 @ $0 · Sale (S): 3,957 @ $26.28 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,859 (derivative) @ $0 · +1 more | EDGAR |
| 2026-10-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,786 @ $8.72 · Sale (S): 5,786 @ $23.19 · Option exercise (M): 5,786 (derivative) @ $0 | EDGAR |
| 2026-09-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,787 @ $8.72 · Sale (S): 5,387 @ $25.69 · Sale (S): 400 @ $26.64 · Option exercise (M): 5,787 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,787 @ $8.72 · Sale (S): 16,589 @ $23.05 · Option exercise (M): 5,787 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 3,847 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,221 @ $1.86 · Option exercise (M): 5,787 @ $8.72 · Sale (S): 11,008 @ $23.56 · Option exercise (M): 5,221 (derivative) @ $0 · Option exercise (M): 5,787 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 13,333 @ $7.26 · Option exercise (M): 15,602 @ $8.72 · Sale (S): 28,935 @ $20.06 · Option exercise (M): 13,333 (derivative) @ $0 · Option exercise (M): 15,602 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,422 @ $1.86 · Sale (S): 8,148 @ $16.60 · Option exercise (M): 3,422 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 8,148 @ $16.96 | EDGAR |
| 2026-05-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 5,394 @ $16.76 | EDGAR |
| 2026-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,214 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 8,148 @ $15.24 | EDGAR |
| 2026-03-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 8,148 @ $15.44 | EDGAR |
| 2026-02-10 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Nurix Therapeutics, Inc. (NRIX) | Sale (S): 14,261 @ $16.66 | EDGAR |
| 2026-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,925 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 4,333 @ $16.58 · Sale (S): 88 @ $17.37 · +4 more | EDGAR |
| 2026-01-20 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,760 @ $1.86 · Sale (S): 3,760 @ $18.42 · Option exercise (M): 3,760 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,760 @ $1.86 · Sale (S): 3,560 @ $17.87 · Sale (S): 200 @ $18.55 · Option exercise (M): 3,760 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 37,600 @ $1.86 · Sale (S): 37,600 @ $17.07 · Option exercise (M): 37,600 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,644 @ $12.80 · Option exercise (M): 1,924 (derivative) @ $0 · +3 more | EDGAR |
| 2025-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,841 @ $12.01 · Option exercise (M): 1,924 (derivative) @ $0 · +3 more | EDGAR |
| 2025-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,894 @ $11.50 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-02-13 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 34,300 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 223 @ $1.86 · Option exercise (M): 5,537 @ $1.86 · Sale (S): 5,660 @ $19.94 · Sale (S): 100 @ $20.48 · Option exercise (M): 223 (derivative) @ $0 · Option exercise (M): 5,537 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,929 @ $19.81 · Sale (S): 291 @ $20.33 · Option exercise (M): 1,924 (derivative) @ $0 · +2 more | EDGAR |
| 2025-01-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 5,760 @ $19.50 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 5,760 @ $21.73 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-11-04 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,290 @ $9.57 · Sale (S): 3,290 @ $25 · Option exercise (M): 3,290 (derivative) @ $0 | EDGAR |
| 2024-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 5,760 @ $24.28 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 4,182 @ $24.30 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-10-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 3,290 @ $9.57 · Sale (S): 3,290 @ $25 · Option exercise (M): 3,290 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 5,460 @ $22.19 · Sale (S): 300 @ $22.81 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Option exercise (M): 3,290 @ $9.57 · Sale (S): 8,850 @ $24.93 · Sale (S): 200 @ $25.62 · Option exercise (M): 5,760 (derivative) @ $0 · Option exercise (M): 3,290 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 4,463 @ $1.86 · Option exercise (M): 5,407 @ $9.57 · Sale (S): 9,870 @ $25.01 · Option exercise (M): 4,463 (derivative) @ $0 · Option exercise (M): 5,407 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 5,460 @ $21.39 · Sale (S): 300 @ $22.18 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-07-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,920 @ $20.67 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 5,760 @ $1.86 · Sale (S): 4,959 @ $20.68 · Sale (S): 801 @ $21.57 · Option exercise (M): 5,760 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,864 @ $1.86 · Sale (S): 1,864 @ $17.02 · Option exercise (M): 1,864 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,900 @ $1.86 · Sale (S): 1,900 @ $17.01 · Option exercise (M): 1,900 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 400 @ $1.86 · Sale (S): 400 @ $17.00 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,596 @ $1.86 · Sale (S): 1,596 @ $17.01 · Option exercise (M): 1,596 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,513 @ $12.04 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,760 @ $7.99 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-11-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,232 @ $5.20 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-08-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,420 @ $9.65 · Option exercise (M): 1,924 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Sale (S): 682 @ $9.88 · Option exercise (M): 1,924 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | Nurix Therapeutics, Inc. (NRIX) | Grant/award (A): 88,900 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2023-02-01 | 4 | Nurix Therapeutics, Inc. (NRIX) | Option exercise (M): 1,924 @ $0 · Sale (S): 848 @ $11.78 · Option exercise (M): 1,924 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817199 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs